Thoracoscopic-assisted esophagectomy for esophageal cancer: Analysis of patterns and prognostic factors for recurrence

Annals of Surgery

Volumn 252, Issue 2, 2010, Pages 281-291

  Thomson, Iain G ^a,b   Smithers, Bernard M ^a,b   Gotley, David C ^a,b   Martin, Ian ^a   Thomas, Janine M ^a   O'Rourke, Peter ^c   Barbour, Andrew P ^a,b  

^a Upper Gastrointestinal and Soft Tissue Unit   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORACOSCOPY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THORACOSCOPY;

EID: 77955171611     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181e909a2     Document Type: Article

References (45)

1. Metzger R, Bollschweiler E, Vallbohmer D, et al. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus. 2004;17:310-314.
2. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001; 234:520-530; discussion 530-531.
3. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
4. Johansson J, DeMeester TR, Hagen JA, et al. En bloc vs transhiatal esoph-agectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg. 2004;139:627-631; discussion 631-633.
5. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1000; discussion 1000-1001.
6. Rentz J, Bull D, Harpole D, et al. Transthoracic versus transhiatal esopha-gectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg. 2003;125:1114-1120.
7. Altorki N, Kent M, Ferrara C, Port J, et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002; 236:177-183.
8. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoad-juvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226-234.
9. Siewert JR, Lordick F, Ott K, et al. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg. 2007;246:624-628; discussion 628-631.
10. Stahl M, Wilke H, Stuschke M, et al. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. J Cancer Res Clin Oncol. 2005;131:67-72.
11. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
12. Leibman S, Smithers BM, Gotley DC, et al. Minimally invasive esophagec-tomy: short-and long-term outcomes. Surg Endosc. 2006;20:428-433.
13. Smithers BM, Gotley DC, Martin I, Thomas JM, et al. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245:232-240.
14. Smithers BM, Gotley DC, McEwan D, et al. Thoracoscopic mobilization of the esophagus: a 6 year experience. Surg Endosc. 2001;15:176-182.
15. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486-494; discussion 494-495.
16. Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481-488.
17. de Manzoni G, Pedrazzani C, Pasini F, et al. Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction. Eur J Surg Oncol. 2003;29:506-510.
18. Dresner SM, Griffin SM. Pattern of recurrence following radical oesophage-ctomy with two-field lymphadenectomy. Br J Surg. 2000;87:1426-1433.
19. Hulscher JB, van Sandick JW, Tijssen JG, et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg. 2000;191: 143-148.
20. Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg. 1996;83:107-111.
21. Wayman J, Bennett MK, Raimes SA, et al. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer. 2002;86: 1223-1229.
22. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581-587.
23. Bhansali MS, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg. 1997;21: 275-281.
24. Chen G, Wang Z, Liu XY, et al. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esoph-agectomy. World J Surg. 2007;31:1107-1114.
25. Collard JM, Otte JB, Fiasse R, et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg. 2001;234:25-32.
26. Fujita H, Kakegawa T, Yamana H, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg. 1994;18:266-272.
27. Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616-1623.
28. Mattioli S, Di Simone MP, Ferruzzi L, et al. Surgical therapy for adenocar-cinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus. 2001;14:104-109.
29. Nakagawa S, Kanda T, Kosugi S, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205-211.
30. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemo-radiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6:659-668.
31. Nichols FC, III, Allen MS, Deschamps C, et al. Ivor Lewis esophagogastrec-tomy. Surg Clin North Am. 2005;85:583-592
32. Japanese Gastric Cancer Association. Japanese classification of gastric car-cinoma\2nd English edition. Gastric Cancer. 1998;1:10-24.
33. Greene FL, Page DL, Flemming ID, et al. In: Greene FL, ed. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
34. Dexter SP, Sue-Ling H, McMahon M, et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48:667-670.
35. Law S, Fok M, Chu KM, et al. Thoracoscopic esophagectomy for esophageal cancer. Surgery. 1997;122:8-14.
36. Pennathur A, Farkars A, Krasinskas AM, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87:1048-1054; discussion 1054-1055.
37. Griffin SM, Wayman J. Sub-total oesophagectomy with 2 field lymphade-nectomy. Minerva Chir. 2002;57:753-766.
38. Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364-372; discussion 372-373.
39. Blewett CJ, Miller JD, Ramlawi C, et al. Local recurrence after total or subtotal esophagectomy for esophageal cancer. J Exp Clin Cancer Res. 2001;20:17-19.
40. Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22:1-8.
41. Becker CD, Barbier PA, Terrier F, et al. Patterns of recurrence of esophageal carcinoma after transhiatal esophagectomy and gastric interposition. Am J Roentgenol. 1987;148:273-277.
42. Sagar PM, Johnson D, McMahon MJ, et al. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg. 1993;80:1386-1388.
43. Kim SH, Karpeh MS, Klimstra DS, et al. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg. 1999;3:24-33.
44. Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer. 2002;95:1434-1443.
45. Bollschweiler E, Baldus SE, Schroder W, et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes: are these independent prognostic factors? J Surg Oncol. 2006;94:355-363.